
ELK Biotechnology FRS2 (phospho Tyr436) rabbit pAb
FRS2 (phospho Tyr436) rabbit pAb는 인간 FRS2의 Tyr436 인산화 부위를 인식하는 폴리클로날 항체입니다. WB, IHC, IF, ELISA에 적합하며, 세포 내 신호전달 연구에 활용됩니다. 고순도 IgG 형태로 -20°C에서 1년간 안정적으로 보관 가능합니다.
- 판매단위
- pk
카탈로그
2개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다ELK Biotechnology · ELK Biotechnology FRS2 (phospho Tyr436) rabbit pAb
제품명
FRS2 (phospho Tyr436) rabbit pAb
공급업체
ELK Biotechnology
제품 정보
| 항목 | 내용 |
|---|---|
| Alternative Names | FRS2; Fibroblast growth factor receptor substrate 2; FGFR substrate 2; FGFR-signaling adaptor SNT; Suc1-associated neurotrophic factor target 1; SNT-1 |
| Applications | WB; IHC; IF; ELISA |
| Recommended Dilutions | Western Blot: 1/500 - 1/2000 Immunohistochemistry: 1/100 - 1/300 ELISA: 1/10000 Not yet tested in other applications |
| Immunogen | The antiserum was produced against synthesized peptide derived from human FRS2 around the phosphorylation site of Tyr436 (AA range: 402–451) |
| Host | Rabbit |
| Storage | -20°C / 1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band | 65 kD |
| GeneID (Human) | 10818 |
| Human Swiss-Prot No | Q8WU20 |
| Cellular Localization | Endomembrane system; Cytoplasmic, membrane-bound |
| Species Reactivity | Human; Mouse; Monkey |
Background
Adapter protein that links FGR and NGF receptors to downstream signaling pathways. Involved in the activation of MAP kinases. Modulates signaling via SHC1 by competing for a common binding site on NTRK1.
Phosphorylated on tyrosine residues upon stimulation by NGF. Ubiquitinated when tyrosine phosphorylated and in a complex with GRB2; the unphosphorylated form is not subject to ubiquitination.
Contains 1 IRS-type PTB domain. Cytoplasmic, membrane-bound localization.
Part of a complex containing FRS2, GRB2, and SOS1; also interacts with GRB2 and CBL. Binds RET, FGFR1, SUC1, NTRK1, NTRK2, NTRK3, and SRC.
Highly expressed in heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis.
ELK Biotechnology 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
